Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy

We evaluated SARS-CoV-2 antibody response in voluntary blood donors in Italy at different timepoints. Immediately after lockdown easing, 908/25,657 donors (3.5%) had low IgG titers against nucleocapsid. In the next 2 years, titers increased despite few COVID-19 symptoms. On multivariate analysis, a...

Full description

Bibliographic Details
Main Authors: Martina Ferrari, Lorenza Di Marco, Alessandra Pivetti, Stefania Paduano, Chiara Vecchi, Veronica Bernabucci, Rosina Maria Critelli, Simone Lasagni, Monica De Maria, Donatella Venturelli, Monica Pecorari, Giorgia Boaretto, Giulia Fregni Serpini, Dante Romagnoli, Roberto Mantovani, Giovanni Battista Ceccherelli, Erica Villa
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-07-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
antibodies
blood donor population
serologic analysis
Italy
Online Access:https://wwwnc.cdc.gov/eid/article/29/7/22-1745_article

Internet

https://wwwnc.cdc.gov/eid/article/29/7/22-1745_article

Similar Items